HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Parkinson Disease 5

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Nervous System Diseases: 14178
- Central Nervous System Diseases: 4213
  - Brain Diseases: 15694
    - Basal Ganglia Diseases: 346
      - Parkinsonian Disorders: 9203
        Parkinson Disease 5: 2
  - Movement Disorders: 4634
    - Parkinsonian Disorders: 9203
      - Parkinson Disease 5: 2

Related Diseases

1.	Infections

Experts

1.	Borghammer, Per: 1 article (12/2021)
2.	Cocoros, Noelle M: 1 article (12/2021)
3.	Henderson, Victor W: 1 article (12/2021)
4.	Svensson, Elisabeth: 1 article (12/2021)
5.	Szentkúti, Péter: 1 article (12/2021)
6.	Szépligeti, Szimonetta Komjáthine: 1 article (12/2021)
7.	Sørensen, Henrik Toft: 1 article (12/2021)
8.	Thomsen, Reimar W: 1 article (12/2021)
9.	Vestergaard, Søren Viborg: 1 article (12/2021)
10.	Dijke, Peter Ten: 1 article (01/2020)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Parkinson Disease 5:

1.	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 01/01/2020 - "The probe labels active ubiquitin carboxy-terminal hydrolase L1 (UCHL1), also known as neuron-specific protein PGP9.5 (PGP9.5) and Parkinson disease 5 (PARK5), a DUB active in neurons that constitutes 1 to 2% of the total brain protein. "
2.	Proteins (Proteins, Gene)FDA Link 01/01/2020 - "The probe labels active ubiquitin carboxy-terminal hydrolase L1 (UCHL1), also known as neuron-specific protein PGP9.5 (PGP9.5) and Parkinson disease 5 (PARK5), a DUB active in neurons that constitutes 1 to 2% of the total brain protein. "
3.	ORALIT (ORS)IBA 12/01/2021 - "Crude and adjusted odds ratios (ORs) and 95% CIs were calculated by conditional logistic regression overall and stratified by time between infection and Parkinson disease (5 years or less, more than 5 to 10 years, more than 10 years). "